Verastem (VSTM) Depreciation & Amortization (CF) (2011 - 2016)
Verastem (VSTM) posted quarterly Depreciation & Amortization (CF) of $18000.0 for Q4 2025, up 157.14% year-over-year from $7000.0 in Q4 2024, and up 800.0% quarter-over-quarter from $2000.0 in Q3 2025.
Powered by 
Analysis
Verastem (VSTM) Depreciation & Amortization (CF) (2011 - 2016) Analysis & Trends
Verastem's Depreciation & Amortization (CF) history runs 15 years deep, the most recent figure standing at $18000.0 for Q4 2025.
- In Q4 2025, Depreciation & Amortization (CF) rose 157.14% year-over-year to $18000.0; the TTM figure through Mar 2026 stood at $20000.0 (down 31.03% YoY), while the FY2025 annual figure was $30000.0, up 15.38% from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 stood at $18000.0, up from $2000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $81000.0 in Q1 2021, with the low at $2000.0 in Q3 2025.
- The 5-year median for Depreciation & Amortization (CF) is $22000.0 (2023), against an average of $23210.5.
- The sharpest annual moves came in 2021 and 2025: Depreciation & Amortization (CF) plunged 88.51% in 2021, then jumped 157.14% in 2025.
- Verastem's Depreciation & Amortization (CF) stood at $30000.0 in 2021, then fell by 3.33% to $29000.0 in 2022, then tumbled by 82.76% to $5000.0 in 2023, then jumped by 40.0% to $7000.0 in 2024, then surged by 157.14% to $18000.0 in 2025.
- Business Quant data shows VSTM's Depreciation & Amortization (CF) at $18000.0 in Q4 2025, $2000.0 in Q3 2025, and $10000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Verastem | 815.85 Mn | 679.49 Mn | 36.32 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | 152,000.00 |
| Sep 30, 2016 | 159,000.00 |
| Jun 30, 2016 | 176,000.00 |
| Mar 31, 2016 | 183,000.00 |
| Dec 31, 2015 | 188,000.00 |
| Sep 30, 2015 | 189,000.00 |
| Jun 30, 2015 | 189,000.00 |
| Mar 31, 2015 | 188,000.00 |
| Dec 31, 2014 | 185,000.00 |
| Sep 30, 2014 | 101,000.00 |
| Jun 30, 2014 | 77,000.00 |
| Mar 31, 2014 | 64,000.00 |
| Dec 31, 2013 | 62,000.00 |
| Sep 30, 2013 | 62,000.00 |
| Jun 30, 2013 | 56,000.00 |
| Mar 31, 2013 | 56,000.00 |
| Dec 31, 2012 | 61,000.00 |
| Sep 30, 2012 | 52,000.00 |
| Jun 30, 2012 | 48,000.00 |
| Mar 31, 2012 | 46,000.00 |